ANNISE CLAUDE: Open Payments
NPI 1295014330 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,083 in 83 payments from 22 companies in 2025. Trend: 2023 $2,743 · 2024 $1,869 · 2025 $2,083
Food & beverage: $1,983Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $343 |
| ABBVIE INC. | 7 | $191 |
| PFIZER INC. | 10 | $144 |
| Lilly USA, LLC | 6 | $138 |
| Supernus Pharmaceuticals, Inc. | 1 | $138 |
| Teva Pharmaceuticals USA, Inc. | 5 | $136 |
| HARMONY BIOSCIENCES LLC | 2 | $131 |
| Axsome Therapeutics, Inc. | 5 | $128 |
| Lundbeck LLC | 5 | $126 |
| Genentech USA, Inc. | 4 | $112 |
Products named: KESIMPTA, Qelbree, AUSTEDO XR, NURTEC ODT, VYEPTI, LEQEMBI, Ocrevus Zunovo, UBRELVY.
Industry payments across DC — which companies pay providers there.
